← Leaderboards
Roopa Siddaiah
Pennsylvania State Univ Hershey Med Ctr
$506,660
Attributed
$506,660
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $173.6K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$506,660 · 1
By mechanism
K23$506,660 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Admission Activity”
- John Alam · Eip Pharma, Inc.$10,536,018
- Gary Lessing · Inovodel, Inc.$2,946,822
- Lorraine I Kelley-Quon · Children'S Hospital Of Los Angeles$2,495,528
- Joseph Shapiro · National Bureau Of Economic Research$2,440,931
- Katherine Hoops · Johns Hopkins University$2,401,338
- Timothy William Dunn · Duke University$2,387,866
Research focus
Admission ActivityAlveolarAngiogenesisAspirateBiological Adaptation To StressBiological MarkersBiomarker IdentificationBiomarker PanelBiometryBronchopulmonary DysplasiaCareerCareer DevelopmentCell ProliferationCellsCessation Of LifeChildhoodClassification TreesClinical ResearchClinical TrialsComplexComplicationCorrelation StudiesDesign1 Year Old
Grant awards (3)
Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants$159,422
K23 · FY2025 · HD · contact PI
Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants$173,619
K23 · FY2024 · HD · contact PI
Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants$173,619
K23 · FY2023 · HD · contact PI